Literature DB >> 6096503

Murine forebrain anomalies induced by coxsackievirus B3 variants.

C J Gauntt, D C Jones, H W Huntington, H M Arizpe, R J Gudvangen, R M DeShambo.   

Abstract

Neonatal or 7-day-old mice inoculated intracranially with either of two temperature-sensitive mutants (ts1, ts6) or the parent coxsackievirus B3 (CVB3) subsequently developed porencephaly or hydranencephaly. The forebrain anomaly induced depended upon age of the animal at inoculation and virus variant inoculated. Sections of brains from hydranencephalic mice revealed severe meningeal reactions, necrotizing encephalitis, and liquifactive necrosis in the cerebrum. No pathology was found in the pons, medulla, or cerebellum. Immunofluorescence studies with hyperimmune anti-CVB3 antiserum showed a random distribution of virus-infected cells in the cerebrum. Virus was recovered from several organs but little to no interferon and no anti-CVB3 neutralizing antibody were present in brain tissues. Availability of cells for replication of virus at the time of inoculation and replicative properties of each virus likely contributed to the outcome. Thus, forebrain anomalies resembling those found in infants can be induced in a murine model by select variants of coxsackievirus B3.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096503     DOI: 10.1002/jmv.1890140407

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  2 in total

1.  Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease.

Authors:  Ralph Feuer; Ignacio Mena; Robb R Pagarigan; Stephanie Harkins; Daniel E Hassett; J Lindsay Whitton
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

2.  Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency.

Authors:  Ralph Feuer; Ignacio Mena; Robb R Pagarigan; Daniel E Hassett; J Lindsay Whitton
Journal:  Med Microbiol Immunol       Date:  2003-08-19       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.